Search research articles
Contact Us
Filters
Showing results (141-150 of 144) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 144 results.
Clinical Proteomics
|
September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
Ana M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
Molecular Cancer Therapeutics
|
March 11, 2014
Concordance of genomic alterations between primary and recurrent breast cancer
Funda Meric-Bernstam, Garrett M Frampton, Jaime Ferrer-Lozano, et al.
American Journal of Clinical Pathology
|
October 22, 2015
Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing
Sinchita Roy-Chowdhuri, Debora de Melo Gagliato, Mark J Routbort, et al.
Journal of the National Cancer Institute
|
December 11, 2014
Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies
Matthew P Goetz, James X Sun, Vera J Suman, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 144) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 144 results.
Clinical Proteomics
|
September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
Ana M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
Molecular Cancer Therapeutics
|
March 11, 2014
Concordance of genomic alterations between primary and recurrent breast cancer
Funda Meric-Bernstam, Garrett M Frampton, Jaime Ferrer-Lozano, et al.
American Journal of Clinical Pathology
|
October 22, 2015
Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing
Sinchita Roy-Chowdhuri, Debora de Melo Gagliato, Mark J Routbort, et al.
Journal of the National Cancer Institute
|
December 11, 2014
Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies
Matthew P Goetz, James X Sun, Vera J Suman, et al.
Page
of 15